Latest It Consulting News

Argent Minerals reports exceptional silver grades from deep drilling at Kempfield, alongside bonanza gold results at Trunkey Creek and new copper-gold targets at West Wyalong, supported by a $4.85 million capital raise.

OzAurum Resources reports significant high-grade gold intercepts at its Mulgabbie North project and regains full control of its feasibility study, positioning the company to accelerate development amid record gold prices.

Avira Resources has secured a binding agreement to acquire the high-grade Mt Cattlin Gold Project and raised $2.5 million in firm commitments, positioning itself for significant exploration activity in Western Australia and Sweden.

Micro-X Ltd has secured its largest-ever $3.3 million Rover Plus order from Malaysia’s Ministry of Health and is progressing critical Head CT imaging trials, supported by a $4.4 million government grant.

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug candidate NUZ-001 and strengthened its balance sheet with a $5.2 million capital raise. The company is now poised to enter the pivotal HEALEY ALS Platform Trial, marking a significant step forward in its neurodegenerative disease program.

Apollo Minerals reports encouraging exploration results from its Gabon projects, highlighting significant gold intercepts at Salanie and a substantial zinc-lead target at Kroussou, while navigating funding constraints and ongoing legal challenges in Europe.

Superior Resources has boosted its Greenvale Project area by 56%, revealing exceptional copper-gold-silver assay results and advancing its Steam Engine Gold Project towards production within two years.

Bryah Resources has secured the Golden Pike gold and antimony project in Canada, appointed Greg Hill as CEO, and raised nearly $2 million to fund upcoming drilling and resource upgrades.

ASF Group Limited reported a solid cash position of $2.44 million as of September 2025, driven by strategic investment moves and technology development, while extending its share buyback program.

Argenica Therapeutics reports ARG-007 is safe in acute ischemic stroke patients and shows promising efficacy signals in a high-risk subgroup, paving the way for a focused Phase 2b trial.

West Cobar Metals reports significant progress across its WA and NSW projects, with promising assay results for rare earths and base metals, alongside strategic engagement in the US market and a recent $1.25 million capital raise.

Pathkey.AI reports strong validation of its TrialKey AI platform’s predictive accuracy and announces key leadership changes as it advances toward commercial scale.